New Partnership Aims to Expand Non-Invasive Liver Tumor Treatment in US Hospitals
Proximie has teamed up with HistoSonics to bring the Edison Histotripsy System to more hospitals and surgical centers across the […]
Rising Drug Prices and Patient Access: What You Need to Know
Drug prices, especially those set when new medications first hit the market, are climbing higher and higher, according to the
New Depression Treatment Trial Begins with First Patient Dosed
Seaport Therapeutics has started its phase 2b BUOY-1 trial for GlyphAllo, a new oral medication for major depressive disorder (MDD),
Biotech Industry Faces Uncertain Times, But Hope Lies in Upcoming Drug Trials
The biotech world is going through a tough time right now. So far this year, big companies buying smaller ones
New Approach to Treating Chronic Pain Shows Promise
A recent study has found that a new type of medication may be effective in managing chronic pain. This new
Pharmaceutical News
New Cholesterol Drug Shows Promise
A recently conducted study revealed that a new medication, known as Inclisiran, has shown promising results in lowering cholesterol levels.
Important Update on a New Cholesterol-Lowering Drug
There’s good news for those managing high cholesterol levels. A new drug has been shown to significantly reduce ‘bad’ cholesterol,
Pharmaceutical News
New Developments in Medicine Production and Quality Control
Several exciting updates are happening in the world of pharmaceuticals! Here’s a simple breakdown: 1. **Improving Drug Absorption**: There’s a
New Study: Antibiotics Often Prescribed Unnecessarily for Common Cold
A recent study published in the journal ‘Family Practice’ reveals that many doctors are still prescribing antibiotics for common colds,
Uncategorized
Lilly plans to invest $50 billion to expand its manufacturing facilities in the United States. This investment will help produce more medications, including well-known pills like Trulicity and Jardiance, to meet growing demand.
The company is planning to double its investment in U.S. factories. This is happening because President Donald Trump is pushing the pharmaceutical industry to bring drug production back to the United States. Some of the medicines that might be affected include common ones like aspirin or ibuprofen.